It's mostly a timing thing. H1, only included marginal cost's relating to new facilities. H2 will be the first period to include the full 6 months worth. (though for S2 the full facility costs will show up from FY19H2)
The new facilities will have an initial negative effect on Operating Leverage. (cost's rising faster than revenue as a result of high initial fixed costs). i.e. they are cashflow negative.
Keep in mind that's 9 MW's in 6 months of 'Contracted Utilitisation'. Which is a fundamentally different thing from billed utilisation. It will likely be realised over year's.
We also don't know the nature of the 9MW's (I'd speculate a big component is from whitespace which is lumpy and probably has different revenue considerations).
Will be interesting to see what Project Revenue is for S1 next period as well as increases in recurring revenue without a comparative change in the Billing Utilisation rate.
- Forums
- ASX - By Stock
- NXT
- Ann: Half Year Results Announcement
NXT
nextdc limited
Add to My Watchlist
1.05%
!
$14.19

Ann: Half Year Results Announcement, page-32
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.19 |
Change
-0.150(1.05%) |
Mkt cap ! $9.087B |
Open | High | Low | Value | Volume |
$14.51 | $14.63 | $14.17 | $35.40M | 2.482M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 32553 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.28 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 420 | 14.160 |
5 | 2064 | 14.100 |
1 | 2000 | 14.030 |
1 | 2000 | 14.020 |
2 | 284 | 14.010 |
Price($) | Vol. | No. |
---|---|---|
14.450 | 200 | 1 |
14.590 | 1000 | 1 |
14.600 | 500 | 1 |
14.640 | 500 | 1 |
14.690 | 687 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online